Literature DB >> 28714275

Fucoidan-induced osteogenic differentiation promotes angiogenesis by inducing vascular endothelial growth factor secretion and accelerates bone repair.

Beom-Su Kim1,2,3, Sun-Sik Yang1, Hyung-Keun You4, Hong-In Shin5, Jun Lee1,6.   

Abstract

Osteogenesis and angiogenesis, including cell-cell communication between blood vessel cells and bone cells, are essential for bone repair. Fucoidan is a chemical compound that has a variety of biological activities. It stimulates osteoblast differentiation in human mesenchymal stem cells (MSCs), which in turn induces angiogenesis. However, the mechanism by which this communication between osteoblasts and endothelial cells is mediated remains unclear. Thus, the aim of this study was to clarify the relationship between fucoidan-induced osteoblastic differentiation in MSCs and angiogenesis in endothelial cells. First, the effect was confirmed of fucoidan on osteoblast differentiation in MSCs and obtained conditioned media from these cells (Fucoidan-MSC-CM). Next, the angiogenic activity of Fucoidan-MSC-CM was investigated and it was found that it stimulated angiogenesis, demonstrated by proliferation, tube formation, migration and sprout capillary formation in human umbilical vein endothelial cells. Messenger ribonucleic acid expression and protein secretion of vascular endothelial growth factor (VEGF) were dramatically increased during fucoidan-induced osteoblast differentiation and that its angiogenic activities were reduced by a VEGF/VEGF receptor-specific binding inhibitor. Furthermore, Fucoidan-MSC-CM increased the phosphorylation of mitogen-activated protein kinase and PI3K/AKT/eNOS signalling pathway, and that its angiogenic effects were markedly suppressed by SB203580 and AKT 1/2 inhibitor. Finally, an in vivo study was conducted and it was found that fucoidan accelerated new blood vessel formation and partially promoted bone formation in a rabbit model of a calvarial bone defect. This is the first study to investigate the angiogenic effect of fucoidan-induced osteoblastic differentiation through VEGF secretion, suggesting the therapeutic potential of fucoidan for enhancing bone repair.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  angiogenesis; bone regeneration; fucoidan; mesenchymal stem cell; osteogenic differentiation; vascular endothelial growth factor

Mesh:

Substances:

Year:  2017        PMID: 28714275     DOI: 10.1002/term.2509

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  9 in total

Review 1.  Fucoidan from Marine Macroalgae: Biological Actions and Applications in Regenerative Medicine, Drug Delivery Systems and Food Industry.

Authors:  Grace Sathyanesan Anisha; Savitha Padmakumari; Anil Kumar Patel; Ashok Pandey; Reeta Rani Singhania
Journal:  Bioengineering (Basel)       Date:  2022-09-14

Review 2.  Bioactive Compounds from Marine Organisms: Potential for Bone Growth and Healing.

Authors:  Matthew A Carson; Susan A Clarke
Journal:  Mar Drugs       Date:  2018-09-18       Impact factor: 5.118

3.  Mettl3 Regulates Osteogenic Differentiation and Alternative Splicing of Vegfa in Bone Marrow Mesenchymal Stem Cells.

Authors:  Cheng Tian; Yanlan Huang; Qimeng Li; Zhihui Feng; Qiong Xu
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

4.  Antioxidant Fucoidans Obtained from Tropical Seaweed Protect Pre-Osteoblastic Cells from Hydrogen Peroxide-Induced Damage.

Authors:  Gabriel Pereira Fidelis; Cynthia Haynara Ferreira Silva; Leonardo Thiago Duarte Barreto Nobre; Valquíria Pereira Medeiros; Hugo Alexandre Oliveira Rocha; Leandro Silva Costa
Journal:  Mar Drugs       Date:  2019-08-28       Impact factor: 5.118

5.  The Effect of MMP-2 Inhibitor 1 on Osteogenesis and Angiogenesis During Bone Regeneration.

Authors:  Liangjun Jiang; Kunkun Sheng; Cong Wang; Deting Xue; Zhijun Pan
Journal:  Front Cell Dev Biol       Date:  2021-01-22

Review 6.  Therapeutic activity of fucoidan and carrageenan as marine algal polysaccharides against viruses.

Authors:  Najmeh Oliyaei; Marzieh Moosavi-Nasab; Seyed Mohammad Mazloomi
Journal:  3 Biotech       Date:  2022-06-25       Impact factor: 2.893

7.  Antioxidant Activity of Fucoidan Modified with Gallic Acid Using the Redox Method.

Authors:  Keylla Dayanne Coelho Marinho de Melo; Lucas Dos Santos Lisboa; Moacir Fernandes Queiroz; Weslley Souza Paiva; Ana Carolina Luchiari; Rafael Barros Gomes Camara; Leandro Silva Costa; Hugo Alexandre Oliveira Rocha
Journal:  Mar Drugs       Date:  2022-07-29       Impact factor: 6.085

8.  Effect of Enzymatically Extracted Fucoidans on Angiogenesis and Osteogenesis in Primary Cell Culture Systems Mimicking Bone Tissue Environment.

Authors:  Julia Ohmes; Yuejun Xiao; Fanlu Wang; Maria Dalgaard Mikkelsen; Thuan Thi Nguyen; Harald Schmidt; Andreas Seekamp; Anne S Meyer; Sabine Fuchs
Journal:  Mar Drugs       Date:  2020-09-21       Impact factor: 5.118

9.  The impact of cardiomotor rehabilitation on endothelial function in elderly patients with chronic heart failure.

Authors:  Juming Chen; Shenhong Gu; Yanling Song; Xinbo Ji; Wangyuan Zeng; Xiaoxi Wang; Yachun Wang; Qingfeng Feng
Journal:  BMC Cardiovasc Disord       Date:  2021-11-01       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.